Target intelligence / Profile preview

Ubiquitin-conjugating enzyme E2I pseudogene

Molecular classification
Pseudogene
01

Overview

The ubiquitin-conjugating enzyme E2I pseudogene (ENSG00000225943) is a genomic region in humans that resembles the UBE2I gene but is nonfunctional and does not code for an active protein. Pseudogenes are nonfunctional segments of DNA similar to known genes, typically rendered inactive by mutations such as frameshifts or early stop codons[4]. While the protein-coding UBE2I gene is central to cellular protein degradation processes via the ubiquitination pathway[1][3], the corresponding pseudogene plays no established biological role and is not used as a therapeutic target. In rare cases, pseudogenes may generate regulatory RNAs, but there is no evidence that this specific pseudogene is functionally significant in health or disease[6]. Key Notes: - Pseudogenes are defined by the lack of protein-coding capacity despite sequence similarity to functional genes[2][4]. - They sometimes complicate genetic studies by sequence similarity but are not pursued as therapeutic drug targets[4]. - The functional UBE2I gene (not this pseudogene) encodes a SUMO-conjugating enzyme involved in many cellular processes, but all known aliases, disease roles, and functions belong to the protein-coding gene, not its pseudogene[1][3].

Other names
UBE2I pseudogeneUBC9 pseudogene
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on Ubiquitin-conjugating enzyme E2I pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-conjugating enzyme E2I pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call